全文获取类型
收费全文 | 1273篇 |
免费 | 102篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 81篇 |
妇产科学 | 31篇 |
基础医学 | 161篇 |
口腔科学 | 12篇 |
临床医学 | 194篇 |
内科学 | 346篇 |
皮肤病学 | 39篇 |
神经病学 | 104篇 |
特种医学 | 18篇 |
外科学 | 112篇 |
综合类 | 4篇 |
预防医学 | 73篇 |
眼科学 | 15篇 |
药学 | 99篇 |
中国医学 | 5篇 |
肿瘤学 | 78篇 |
出版年
2023年 | 15篇 |
2022年 | 24篇 |
2021年 | 45篇 |
2020年 | 32篇 |
2019年 | 48篇 |
2018年 | 60篇 |
2017年 | 33篇 |
2016年 | 41篇 |
2015年 | 49篇 |
2014年 | 45篇 |
2013年 | 57篇 |
2012年 | 88篇 |
2011年 | 77篇 |
2010年 | 44篇 |
2009年 | 55篇 |
2008年 | 84篇 |
2007年 | 91篇 |
2006年 | 70篇 |
2005年 | 50篇 |
2004年 | 56篇 |
2003年 | 64篇 |
2002年 | 38篇 |
2001年 | 22篇 |
2000年 | 27篇 |
1999年 | 29篇 |
1998年 | 11篇 |
1997年 | 11篇 |
1996年 | 5篇 |
1995年 | 10篇 |
1994年 | 9篇 |
1993年 | 2篇 |
1992年 | 15篇 |
1991年 | 7篇 |
1990年 | 6篇 |
1989年 | 2篇 |
1988年 | 9篇 |
1987年 | 6篇 |
1986年 | 6篇 |
1985年 | 8篇 |
1984年 | 1篇 |
1983年 | 3篇 |
1981年 | 3篇 |
1979年 | 2篇 |
1976年 | 1篇 |
1975年 | 4篇 |
1974年 | 2篇 |
1973年 | 1篇 |
1972年 | 1篇 |
1971年 | 6篇 |
1968年 | 1篇 |
排序方式: 共有1376条查询结果,搜索用时 15 毫秒
91.
The clinical finding that depressive disorders are often associated with desynchronization of internal rhythms has encouraged the idea that resetting normal circadian rhythms may have antidepressant potential. Agomelatine, a naphthalene analog of melatonin, is both an agonist of human cloned melatonergic MT1 and MT2 receptors and a serotonin 5-HT2C receptor antagonist. Agomelatine combines zeitgeber (synchroniser of the circadian system) activity with neurotransmitter augmentation properties (enhances the levels of dopamine and noradrenaline in frontal cortex). The efficacy of agomelatine in treating depression has been shown in three short-term, pivotal, randomized, placebo-controlled studies. These studies have demonstrated agomelatine to be efficacious in Major Depressive Disorder at the standard dose of 25mg/day, with the possibility of increasing doses to 50mg/day in those patients with insufficient improvement. The number of adverse events during the treatment period was comparable to placebo. Four studies have shown the positive effect of agomelatine on sleep continuity and quality and shortening of sleep latency. Despite these promising data, further studies are needed to examine agomelatine's efficacy over a longer treatment period. 相似文献
92.
Filip Lim Gloria M Palomo Christina Mauritz Alfredo Giménez-Cassina Belen Illana Francisco Wandosell Javier Díaz-Nido 《Molecular therapy》2007,15(6):1072-1078
There is currently no effective treatment for Friedreich's ataxia (FA), the most common of the hereditary ataxias. The disease is caused by mutations in FRDA that drastically reduce expression levels of the mitochondrial protein frataxin. In FA animal models, a key difficulty is obtaining the precise levels of frataxin expression in the appropriate tissues to provoke pathology without early lethality. To develop strategies to circumvent these problems, conditional frataxin transgenic mice have been generated. We now show that frataxin expression can be eliminated in neurons from these loxP[frda] mice by infection with CRE-expressing herpes simplex virus type 1 (HSV-1) amplicon vectors. We have also achieved in vivo delivery by stereotaxic injection of these CRE-expressing vectors into the brainstem of loxP[frda] mice to generate a localized gene knockout model. These mice develop a behavioral deficit in the rotarod assay detectable after 4 weeks, and when re-injected with HSV-1 amplicon vectors expressing human frataxin complementary DNA (cDNA) exhibit behavioral recovery as early as 4 weeks after the second injection. To the best of our knowledge, this is the first proof of principle of recovery of neurological function by a therapeutic agent aimed at correcting frataxin deficiency. 相似文献
93.
Meeting report: FDA public meeting on patient‐focused drug development and medication adherence in solid organ transplant patients
下载免费PDF全文
![点击此处可从《American journal of transplantation》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Robert Ettenger Renata Albrecht Rita Alloway Ozlem Belen Marc W. Cavaillé‐Coll Marie A. Chisholm‐Burns Mary Amanda Dew William E. Fitzsimmons Peter Nickerson Graham Thompson Pujita Vaidya 《American journal of transplantation》2018,18(3):564-573
The Food and Drug Administration (FDA) held a public meeting and scientific workshop in September 2016 to obtain perspectives from solid organ transplant recipients, family caregivers, and other patient representatives. The morning sessions focused on the impact of organ transplantation on patients’ daily lives and the spectrum of activities undertaken to maintain grafts. Participants described the physical, emotional, and social impacts of their transplant on daily life. They also discussed their posttransplant treatment regimens, including the most burdensome side effects and their hopes for future treatment. The afternoon scientific session consisted of presentations on prevalence and risk factors for medication nonadherence after transplantation in adults and children, and interventions to manage it. As new modalities of Immunosuppressive Drug Therapy are being developed, the patient perceptions and input must play larger roles if organ transplantation is to be truly successful. 相似文献
94.
Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children 总被引:3,自引:0,他引:3
Rey C Los Arcos M Concha A Medina A Prieto S Martinez P Prieto B 《Intensive care medicine》2007,33(3):477-484
OBJECTIVES: To analyse the clinical value of procalcitonin (PCT), C-reactive protein (CRP) and leucocyte count in the diagnosis of paediatric sepsis and in the stratification of patients according to severity. DESIGN: Prospective, observational study. SETTING: Paediatric intensive care unit (PICU). PATIENTS: Ninety-four children. MEASUREMENT AND RESULTS: Leucocyte count, PCT and CRP were measured when considered necessary during the PICU stay. Patients were classified, when PCT and CRP were measured, into one of six categories (negative, SIRS, localized infection, sepsis, severe sepsis, and septic shock) according to the definitions of the American College of Chest Physicians /Society of Critical Care Medicine. A total of 359 patient day episodes were obtained. Leucocyte count did not differ across the six diagnostic classes considered. Median plasma PCT concentrations were 0.17, 0.43, 0.79, 1.80, 15.40 and 19.13 ng/ml in negative, systemic inflammatory response syndrome (SIRS), localized infection, sepsis, severe sepsis, and septic shock groups, respectively, whereas median plasma CRP concentrations were 1.35, 3.80, 6.45, 5.70, 7.60 and 16.2 mg/dl, respectively. The area under the ROC curve for the diagnosis of septic patients was 0.532 for leucocyte count (95% CI, 0.462-0.602), 0.750 for CRP (95% CI, 0.699-0.802) and 0.912 for PCT (95% CI, 0.882-0.943). We obtained four groups using CRP values and five groups using PCT values that classified a significant percentage of patients according to the severity of the different SIRS groups. CONCLUSIONS: PCT is a better diagnostic marker of sepsis in critically ill children than CRP. The CRP, and especially PCT, may become a helpful clinical tool to stratify patients with SIRS according to disease severity. 相似文献
95.
Paula GarciaEsparcia Anusha Koneti M. Cruz RodríguezOroz Belen Gago Jos Antonio del Rio Isidro Ferrer 《Brain pathology (Zurich, Switzerland)》2018,28(1):43-57
Altered mitochondrial function is characteristic in the substantia nigra in Parkinson's disease (PD). Information about mitochondria in other brain regions such as the cerebral cortex is conflicting mainly because most studies have not contemplated the possibility of variable involvement depending on the region, stage of disease progression and clinical symptoms such as the presence or absence of dementia. RT‐qPCR of 18 nuclear mRNAs encoding subunits of mitochondrial complexes and 12 mRNAs encoding energy metabolism‐related enzymes; western blotting of mitochondrial proteins; and analysis of enzymatic activities of complexes I, II, II, IV and V of the respiratory chain were assessed in frontal cortex area 8 and the angular gyrus of middle‐aged individuals (MA), and those with incidental PD (iPD), long‐lasting PD with parkinsonism without dementia (PD) and long‐lasting PD with dementia (PDD). Up‐regulation of several genes was found in frontal cortex area 8 in PD when compared with MA and in the angular gyrus in iPD when compared with MA. Marked down‐regulation of genes encoding mitochondrial subunits and energy metabolism‐related enzymes occurs in frontal cortex but only of genes coding for energy metabolism‐related enzymes in the angular gyrus in PDD. Significant decrease in the protein expression levels of several mitochondrial subunits encoded by these genes occurs in frontal cortex area 8 and angular gyrus in PDD. Moreover, expression of MT‐ND1 which is encoded by mitochondrial DNA is also reduced in PDD. Reduced enzymatic activity of complex III in frontal cortex area 8 and angular gyrus is observed in PD, but dramatic reduction in the activity of complexes I, II, II and IV in both regions characterizes PDD. Dementia in the context of PD is linked to region‐specific deregulation of genomic genes encoding subunits of mitochondrial complexes and to marked reduction in the activity of mitochondrial complexes I, II, III and IV. 相似文献
96.
Childhood Lead Poisoning on the US-Mexico Border: A Case Study in Environmental Health Nursing Lead Poisoning 总被引:1,自引:0,他引:1
Maria Alvarez Amaya R.N.C. Ph.D. WHNP Gail Ackall Ed.D. M.T. C.L.S. Nicholas Pingitore Ph.D. Martha Quiroga R.N.C. M.S.N. F.N.P. Belen Terrazas-Ponce R.N. B.S.N. 《Public health nursing (Boston, Mass.)》1997,14(6):353-360
Abstract Human exposure to environmental hazards is a major public health problem along the US-Mexico border due to socio-economic, cultural and political factors. Childhood lead exposure is endemic in areas of extreme poverty and substandard housing. Hispanic children of indigent, poorly-educated, disenfranchised families are at disproportionate risk. Risk management is contingent upon consideration of the interrelationships between socioeconomics, politics, and culture. This case study explains childhood lead poisoning in a colonia family living at subsistence level from such a perspective. The purpose of the study was to identify, explain, and ameliorate lead exposure pathways. Case study methodology was used to support or refute the proposition that these children were exposed to occupational lead. The children were the study sampling unit and the family a subunit. An embedded single case explanatory design was appropriate. Data were collected from exposure surveys, environmental and blood specimens, and review of medical records. Pattern-matching and explanation-building techniques were used to analyze data. The study illustrated how extreme poverty, lack of access to health services, social isolation, language and legal barriers, and hazardous occupations may be singularly common risk factors for Hispanic children on the US-Maxico border. The study is pertinent to public health nurses who work with this population. 相似文献
97.
98.
Ana P. Silva Isabel Faria-Ramos Elisabete Ricardo Isabel M. Miranda Maria J. Espinar Sofia Costa-de-Oliveira Rafael Cantón Acácio G. Rodrigues Cidália Pina-Vaz 《Antimicrobial agents and chemotherapy》2016,60(6):3824-3826
A flow cytometry test was developed to identify carbapenemase production by Enterobacteriaceae and to discriminate between the different types of carbapenemases (classes A, B, and D). It is based on the detection of meropenem activity against bacteria, coupled with different carbapenemase inhibitors, which is assessed by flow cytometry. It represents a convenient, fast, and reliable approach (100% sensitivity and 100% specificity) for the detection and characterization of different carbapenemases. 相似文献
99.
100.
Trabanco AA Cid JM Lavreysen H Macdonald GJ Tresadern G 《Current medicinal chemistry》2011,18(1):47-68
The metabotropic glutamate type 2 (mGlu2) receptor is a G-protein coupled receptor (GPCR) expressed on presynaptic nerve terminals where it negatively modulates glutamate and GABA release. Mixed mGlu2/mGlu3 orthosteric agonists such as LY354740 have shown activity in a range of preclinical animal models of anxiety and schizophrenia. Clinical work with LY354740 demonstrated activity in a CO(2) inhalation study suggesting application in the treatment of anxiety related disorders. Subsequently, a related prodrug LY2140023 demonstrated improvements in positive and negative symptoms in patients suffering from schizophrenia. These molecules exhibit combined mGlu2/mGlu3 activity although there is evidence from knock-out studies that preclinical anti-psychotic effects may be mediated via the mGlu2 receptor. An alternative avenue for modulating GPCRs is to act via allosteric mechanisms, binding at a different site from the orthosteric agonist. Since the first discovery of mGlu2 positive allosteric modulators (PAMs) such as 2,2,2-TEMPS and BINA, multiple families of mGlu2 modulators have been reported and several have entered into clinical development. This review focuses on recent advances in the development of novel mGlu2 PAMs by analysis of compounds disclosed in research articles and patent literature between 2007 and 2010. 相似文献